SC&H Capital, an investment banking advisory firm focused on M&A and corporate finance solutions, announced today that it has acted as a financial advisor to Southern Maryland Hospital Center in that hospital’s acquisition by MedStar Health. The newly named MedStar Southern Maryland Hospital Center will expand its healthcare offerings, with MedStar Health pledging to invest $100 million in additional medical services and capabilities at the hospital over the next five years.
SC&H Capital was selected by Southern Maryland Hospital as a financial advisor in the transaction because of its highly regarded competencies at preparing and positioning the regional healthcare institution for acquisition before year end 2012. Southern Maryland Hospital Center was comprised of 17 separate business entities, including radiology, and therapeutic and preventative care facilities.
“SC&H Capital cared about our objectives, and applied its expertise to the details – including financial analyses and demographic analytic studies — to demonstrate how to best serve this community’s healthcare needs,” said Michael J. Chiaramonte, president of MedStar Southern Maryland Hospital. “From its thorough data preparation to its role in increasing buyer interest, SC&H Capital has been a close and trusted partner throughout this process.”
The Southern Maryland Hospital Center acquisition is SC&H Capital’s ninth investment banking deal completed in 2012. SC&H Capital has developed expertise in healthcare facility M&A, which requires specialized acumen and preparation in the wake of the Affordable Care Act. This expertise is especially important in valuing a healthcare facility for acquisition, while matching its benefits to buyer interest for future market development opportunities.
“The healthcare regulatory environment is changing, and with that, traditional, community-based healthcare providing institutions are beginning to understand the need to re-evaluate their servicing models,”” said Christopher Helmrath, managing director, SC&H Capital. “At the same time, national or super-regional providers are looking to grow to expand services and capture economies. We are already involved in four other healthcare related deals that we expect to close in early 2013 because of this changing environment.”
About SC&H Capital
SC&H Capital is an investment banking advisory firm providing M&A and corporate finance solutions for middle market companies, notably in healthcare, information technology and government contracting. SC&H Capital supports its investment banking activity with a full suite of strategic and financial resources to assist companies in the development and execution of strategic plans and initiatives. Its advisory services are tailored to ensure clients receive pertinent and valuable advice at every stage of the business life cycle – not just at the time of sale.
SC&H Capital is an affiliate of SC&H Group, an audit, tax, and consulting firm applying “expertise that works” to minimize risk and maximize value. SC&H Group’s practices advise leading companies from emerging businesses to the Fortune 500 on accounting, tax, profitability, and strategy solutions. Clients in all states and worldwide benefit from SC&H Group’s commitment to delivering powerful minds, passionate teams, and proven results on each and every engagement. For more information, visit www.SCandH.com
Securities offered through SC&H Capital Corporation, member FINRA/SIPC.
